Bone Marrow-Derived Mesenchymal Stem Cells and γ-Secretase Inhibitor Treatments Suppress Amyloid-β25–35-Induced Cognitive Impairment in Rat Dams and Cortical Degeneration in Offspring

Figure 15

Effect of the treatment with MSCs and GSI-953 on (a) p-Tau and (b) APP protein concentration in the newborn cortex of Aβ25–35-induced Alzheimer’s disease dams using the Western blotting technique. Data are expressed as . , , and vs. the saline-injected group. ^#, ^##, and ^### vs. the AD group. ns: nonsignificant ().